Kantipur Pharmaceuticals Lab has received official approval from the Securities Board of Nepal to issue its initial public offering (IPO) to the general public.
Through this share issuance, the company will offer 1.7 million units of shares, which amounts to 17 crore rupees or 21.25 percent of its total paid-up capital. Muktinath Capital has been appointed as the issue and sales manager for managing the share process.
Established as an animal health company, Kantipur Pharmaceuticals Lab focuses on researching, producing, and distributing veterinary medicines, animal nutrition products, and related health items.
Its manufacturing plant is located in Shikharpur, Panchkhal-7 in Kavre, while its corporate office is situated in Balkumari, Lalitpur.
